Compare UFPT & WD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UFPT | WD |
|---|---|---|
| Founded | 1963 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 1996 | 2010 |
| Metric | UFPT | WD |
|---|---|---|
| Price | $238.80 | $48.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $289.00 | $76.00 |
| AVG Volume (30 Days) | 174.0K | ★ 259.5K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 5.34% |
| EPS Growth | ★ 15.44 | N/A |
| EPS | ★ 2.24 | 0.46 |
| Revenue | $602,797,000.00 | ★ $1,234,306,000.00 |
| Revenue This Year | $8.12 | $20.60 |
| Revenue Next Year | $5.72 | $7.79 |
| P/E Ratio | $105.45 | ★ $101.76 |
| Revenue Growth | ★ 19.50 | 8.99 |
| 52 Week Low | $173.86 | $42.12 |
| 52 Week High | $279.49 | $90.00 |
| Indicator | UFPT | WD |
|---|---|---|
| Relative Strength Index (RSI) | 46.07 | 44.22 |
| Support Level | $224.12 | $47.77 |
| Resistance Level | $255.50 | $52.22 |
| Average True Range (ATR) | 10.89 | 1.72 |
| MACD | -2.61 | -0.33 |
| Stochastic Oscillator | 17.09 | 31.79 |
UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of its total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.